Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients
- 23 April 2022
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 57 (7) , 1079-1085
Abstract
The use of opioids and/or benzodiazepines in older adults (65 y+) who received an allogeneic hematopoietic cell transplant (HCT) is not known. In March 2016, the CDC released its strongest guidelines against prescription of opioids and co-prescription of opioids + benzodiazepines. We evaluated the use of opioids and/or benzodiazepines in older (65 y + , n = 114) vs. younger (40–64 y, n = 240) allogeneic-HCT recipients before and after the CDC guidelines. The proportion of patients with >10-days of use of opioids and/or benzodiazepines peri-HCT (day-14 to +28) was compared. Opioids: the older (65 + y) group had similar odds of receiving opioids as the younger group (40–64 y) [O.R. 0.7 (95%CI:0.4-1.2)]. Those transplanted after the CDC guideline had 0.4 (95%CI:0.2–0.7) times the odds of receiving opioids. Benzodiazepines: The older (65 + y) group was 0.6 times (95%CI:0.3–0.9) as likely to receive benzodiazepines. There was no significant change in benzodiazepines use after the CDC guideline. Opioids + Benzodiazepines: The older group (65 + y) was 0.5 (95%CI:0.3–0.9) times as likely to receive both opioids+benzodiazepines. There was no significant change in opioids+benzodiazepines use after the CDC guideline. Though we observed a significant decrease in use of opioids after the CDC guideline, the use of benzodiazepines and combined opioids+benzodiazepines remained constant. Older recipients (65 + y) received less opioids, benzodiazepines, and combined opioids+benzodiazepines.Keywords
This publication has 26 references indexed in Scilit:
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationBlood, 2014
- Gender and Polypharmacotherapy in the Elderly: A Clinical Challenge2012
- Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: A hospital-based studyArchives of Gerontology and Geriatrics, 2012
- Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitalsEuropean Journal of Clinical Pharmacology, 2011
- Opioid Use at the End of Life and Survival in a Hospital at Home UnitJournal of Palliative Medicine, 2010
- Potentially inappropriate prescribing and cost outcomes for older people: a national population studyBritish Journal of Clinical Pharmacology, 2010
- An Introduction to Cancer CareEuropean Journal of Cancer Care, 2008
- Relationship Between Early Opioid Prescribing for Acute Occupational Low Back Pain and Disability Duration, Medical Costs, Subsequent Surgery and Late Opioid UseSpine, 2007
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomitingCanadian Journal of Physiology and Pharmacology, 1990